U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential

Ascendis Pharma

Market Cap: US$12.3b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$12.3b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Alnylam Pharmaceuticals

Market Cap: US$59.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Exelixis

Market Cap: US$11.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Tempus AI

Market Cap: US$12.7b

Operates as a healthcare technology company.

Insmed

Market Cap: US$41.3b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

BeOne Medicines

Market Cap: US$38.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

BridgeBio Pharma

Market Cap: US$12.8b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Eli Lilly

Market Cap: US$885.2b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Ionis Pharmaceuticals

Market Cap: US$11.7b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Exact Sciences

Market Cap: US$12.8b

Provides cancer screening and diagnostic test products in the United States and internationally.

AbbVie

Market Cap: US$398.0b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Neurocrine Biosciences

Market Cap: US$14.7b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Natera

Market Cap: US$28.5b

A diagnostics company, provides molecular testing services worldwide.

Royalty Pharma

Market Cap: US$22.5b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Medpace Holdings

Market Cap: US$17.0b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Viatris

Market Cap: US$12.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Elanco Animal Health

Market Cap: US$11.4b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$10.7b

Provides health sciences solutions, technologies, and services.

Teva Pharmaceutical Industries

Market Cap: US$28.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BioMarin Pharmaceutical

Market Cap: US$10.6b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.